DK2699575T3 - Triazolopyridiner - Google Patents

Triazolopyridiner

Info

Publication number
DK2699575T3
DK2699575T3 DK12721779.2T DK12721779T DK2699575T3 DK 2699575 T3 DK2699575 T3 DK 2699575T3 DK 12721779 T DK12721779 T DK 12721779T DK 2699575 T3 DK2699575 T3 DK 2699575T3
Authority
DK
Denmark
Prior art keywords
triazolopyridines
Prior art date
Application number
DK12721779.2T
Other languages
English (en)
Inventor
Dirk Kosemund
Antje Margret Wengner
Gerhard Siemeister
Detlef Stöckigt
Philip Lienau
Hartmut Schirok
Hans Briem
Volker Schulze
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Application granted granted Critical
Publication of DK2699575T3 publication Critical patent/DK2699575T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK12721779.2T 2011-04-21 2012-04-16 Triazolopyridiner DK2699575T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11163342 2011-04-21
EP11167872 2011-05-27
PCT/EP2012/056914 WO2012143329A1 (en) 2011-04-21 2012-04-16 Triazolopyridines

Publications (1)

Publication Number Publication Date
DK2699575T3 true DK2699575T3 (da) 2015-06-22

Family

ID=46124297

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12721779.2T DK2699575T3 (da) 2011-04-21 2012-04-16 Triazolopyridiner

Country Status (39)

Country Link
US (1) US20140120087A1 (da)
EP (1) EP2699575B1 (da)
JP (1) JP5989091B2 (da)
KR (1) KR20140025470A (da)
CN (1) CN103608350B (da)
AP (1) AP3491A (da)
AR (1) AR086191A1 (da)
AU (1) AU2012244859B2 (da)
CA (1) CA2833657A1 (da)
CL (1) CL2013003044A1 (da)
CO (1) CO6801751A2 (da)
CR (1) CR20130539A (da)
CY (1) CY1116439T1 (da)
DK (1) DK2699575T3 (da)
DO (1) DOP2013000244A (da)
EA (1) EA023766B1 (da)
EC (1) ECSP13013011A (da)
ES (1) ES2539265T3 (da)
GT (1) GT201300254A (da)
HK (1) HK1190398A1 (da)
HR (1) HRP20150517T1 (da)
HU (1) HUE025496T2 (da)
IL (1) IL228704A0 (da)
JO (1) JO3040B1 (da)
MA (1) MA35049B1 (da)
ME (1) ME02143B (da)
MX (1) MX348783B (da)
MY (1) MY164939A (da)
PE (1) PE20141351A1 (da)
PL (1) PL2699575T3 (da)
PT (1) PT2699575E (da)
RS (1) RS54044B1 (da)
SA (1) SA112330466B1 (da)
SG (1) SG194003A1 (da)
SI (1) SI2699575T1 (da)
TW (1) TWI558703B (da)
UY (1) UY34034A (da)
WO (1) WO2012143329A1 (da)
ZA (1) ZA201308707B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2833377C (en) 2011-04-21 2019-02-12 Gilead Sciences, Inc. Benzothiazole compounds and their pharmaceutical use
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk
US9376392B2 (en) 2012-01-04 2016-06-28 Gilead Sciences, Inc. 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
US9284323B2 (en) 2012-01-04 2016-03-15 Gilead Sciences, Inc. Naphthalene acetic acid derivatives against HIV infection
CN104284896B (zh) 2012-03-14 2016-06-01 拜耳知识产权有限责任公司 取代的咪唑并哒嗪
WO2014009219A1 (en) * 2012-07-10 2014-01-16 Bayer Pharma Aktiengesellschaft Method for preparing substituted triazolopyridines
WO2014020041A1 (en) 2012-08-02 2014-02-06 Bayer Pharma Aktiengesellschaft Combinations for the treatment of cancer
WO2014020043A1 (en) 2012-08-02 2014-02-06 Bayer Pharma Aktiengesellschaft Combinations for the treatment of cancer
WO2014195274A1 (en) * 2013-06-07 2014-12-11 Bayer Pharma Aktiengesellschaft Substituted triazolopyridines
CA2914521A1 (en) * 2013-06-07 2014-12-11 Bayer Pharma Aktiengesellschaft Substituted triazolopyridines having activity as mps-1 inhibitors
CA2914668A1 (en) * 2013-06-10 2014-12-18 Volker Schulze Novel compounds for the treatment of cancer
AP2015008898A0 (en) * 2013-06-11 2015-12-31 Bayer Pharma AG Prodrug derivatives of substituted triazolopyridines
CA2914742A1 (en) * 2013-06-11 2014-12-18 Bayer Pharma Aktiengesellschaft Handovers with co-operating cells configured to provide coordinated multi-point transmission/reception
EP2860177A3 (en) 2013-09-20 2015-06-10 Bayer Intellectual Property GmbH Synthesis of functionalized arenes
PL3283642T3 (pl) 2015-04-17 2024-04-22 Crossfire Oncology Holding B.V. Biomarkery prognostyczne dla chemioterapii inhibitorem TTK
WO2018166493A1 (zh) * 2017-03-16 2018-09-20 江苏恒瑞医药股份有限公司 杂芳基并[4,3-c]嘧啶-5-胺类衍生物、其制备方法及其在医药上的应用
CA3137152A1 (en) 2019-04-18 2020-10-22 The Johns Hopkins University Substituted 2-amino-pyrazolyl-[1,2,4]triazolo[1,5a] pyridine derivatives and use thereof
EP3994132A1 (en) 2019-07-03 2022-05-11 Sumitomo Dainippon Pharma Oncology, Inc. Tyrosine kinase non-receptor 1 (tnk1) inhibitors and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
ES2315909T3 (es) 2004-08-17 2009-04-01 GALDERMA RESEARCH & DEVELOPMENT Nuevos compuestos bioaromaticos que son activadores de los receptores del tipo ppar y su utilizacion en composiciones cosmeticas y farmaceuticas.
CN103641829A (zh) * 2006-08-30 2014-03-19 塞尔佐姆有限公司 作为激酶抑制剂的三唑衍生物
AU2008277628B2 (en) 2007-07-18 2012-03-15 Novartis Ag Bicyclic heteroaryl compounds and their use as kinase inhibitors
BRPI0815709A2 (pt) 2007-08-23 2017-06-13 Astrazeneca Ab composro, composição farmacêutica, e, uso de um composto.
CA2691448A1 (en) * 2007-08-31 2009-03-05 Dominique Swinnen Triazolopyridine compounds and their use as ask inhibitors
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
UA102828C2 (en) * 2007-11-27 2013-08-27 Целльзом Лимитед Amino triazoles as p13k inhibitors
CA2751517A1 (en) 2009-02-13 2010-08-19 Fovea Pharmaceuticals [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
CN102413831B (zh) 2009-04-29 2014-06-04 拜耳知识产权有限责任公司 取代的咪唑并喹喔啉
CA2772790C (en) 2009-09-04 2017-06-27 Benjamin Bader Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
EP2343297A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
UY33452A (es) * 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas

Also Published As

Publication number Publication date
DOP2013000244A (es) 2014-03-16
TW201245194A (en) 2012-11-16
ME02143B (me) 2015-10-20
EP2699575A1 (en) 2014-02-26
NZ616456A (en) 2015-09-25
UY34034A (es) 2012-11-30
HRP20150517T1 (hr) 2015-06-19
PL2699575T3 (pl) 2015-08-31
HUE025496T2 (en) 2016-04-28
US20140120087A1 (en) 2014-05-01
EP2699575B1 (en) 2015-03-25
ZA201308707B (en) 2016-07-27
MX2013012289A (es) 2013-11-21
MX348783B (es) 2017-06-28
WO2012143329A1 (en) 2012-10-26
MA35049B1 (fr) 2014-04-03
CR20130539A (es) 2013-12-04
JP5989091B2 (ja) 2016-09-07
AU2012244859B2 (en) 2017-06-08
PE20141351A1 (es) 2014-11-01
ES2539265T3 (es) 2015-06-29
AP3491A (en) 2015-12-31
AP2013007182A0 (en) 2013-10-31
CY1116439T1 (el) 2017-02-08
CO6801751A2 (es) 2013-11-29
EA201301181A1 (ru) 2014-08-29
AR086191A1 (es) 2013-11-27
CA2833657A1 (en) 2012-10-26
CN103608350B (zh) 2015-11-25
PT2699575E (pt) 2015-07-29
CL2013003044A1 (es) 2014-05-02
IL228704A0 (en) 2013-12-31
GT201300254A (es) 2015-09-01
AU2012244859A1 (en) 2013-10-31
TWI558703B (zh) 2016-11-21
JP2014511887A (ja) 2014-05-19
SG194003A1 (en) 2013-11-29
KR20140025470A (ko) 2014-03-04
ECSP13013011A (es) 2013-12-31
MY164939A (en) 2018-02-15
CN103608350A (zh) 2014-02-26
SA112330466B1 (ar) 2015-09-28
EA023766B1 (ru) 2016-07-29
RS54044B1 (en) 2015-10-30
HK1190398A1 (zh) 2014-07-04
JO3040B1 (ar) 2016-09-05
SI2699575T1 (sl) 2015-10-30

Similar Documents

Publication Publication Date Title
CO6980657A2 (es) Triazolopiridinas sustituidas
DK2744810T4 (da) Tenofovir-alafenamid-hemifumarat
CO6801751A2 (es) Triazolopiridinas
DK2769050T3 (da) Propsensor
BR112014000879A2 (pt) deflegmador
DK3272861T3 (da) Alpha-galactosidase-sammensætninger
CO6960543A2 (es) 2-tiopirimidinonas
DE102011100082A8 (de) Traygreifvorrichtung
DK3141251T3 (da) Koloskopi - forberedelse
DE112011104936A5 (de) Stanzstauchniet
DE112012000958A5 (de) Handsäge
DK2476953T3 (da) Fluidbedkedel
DE112012002458A5 (de) Hydrotransformator
DE112012000819A5 (de) Gurtbandfänger
DE112012005313A5 (de) Leuchtbild
DK2526750T3 (da) Høbjærgningsmaskine
DE112012001294T8 (de) Umspritzungsverfahren
DE102011117169A8 (de) Absetzplattenanordnung
DE112011105396A5 (de) Nachverfestigungsverfahren
DK2681057T3 (da) Nanofiber-mærkning
ES1076319Y (es) Minisalvavidas acuatico
ES1075696Y (es) Calzoncillo
ES1075978Y (es) Cucharon-colador-trasvasador
ES1075445Y (es) Cubierto
ES1075621Y (es) Minialetas